{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:09:08Z","timestamp":1775560148401,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hereditary angioedema (HAE) represents a specific form of life-threatening inborn errors of immunity. Current guidelines recommend regular assessment of the disease burden, disease control and quality of life. This study describes the profile of HAE patients in Slovakia, disease control, quality of life, states of anxiety and depression, and socioeconomic situation. Materials and Methods: We used a set of standardized questionnaires\u2014AE-QoL, AECT, HADS and Socioeconomic Status Questionnaire, and a non-standardized questionnaire\u2014to describe the characteristics of the population. Results: We collected data on 56.44% (57 out of 101) of HAE adult patients registered in Slovakia. Moderate to severe HAE was present in 61.40% of patients; 73.68% were on long-term prophylactic treatment; and 19.30% received rescue treatment due to an acute HAE attack during the last 4 weeks. Most patients achieved lower AE-QoL scores, indicating a good quality of life. The AECT score indicated well-controlled disease in 91.23% of patients. Anxiety and\/or depression scores were higher than normal in 17.54% of patients. Patients with HAE earned less than the average population, but most of them were economically active with relatively low rates of presenteeism and absenteeism. Only a minority of patients used social system benefits. Patients were exclusively cared for by relatives. Conclusions: The QoL scores achieved in all three standardized questionnaires indicate a good quality of life of HAE patients in Slovakia, which is associated with a high and specialized standard of care. Anxiety and\/or depression were present in 17.54% of patients. Direct patients costs and social care costs are low, but there is an indirect socioeconomic burden on patients and their families.<\/jats:p>","DOI":"10.3390\/medicina62040705","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:40:31Z","timestamp":1775554831000},"page":"705","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of Life and Socioeconomic Situation of Patients with Hereditary Angioedema in Slovakia"],"prefix":"10.3390","volume":"62","author":[{"given":"Martina","family":"Ondru\u0161ov\u00e1","sequence":"first","affiliation":[{"name":"PharmIn Ltd., Karad\u017ei\u010dova 16, 82108 Bratislava, Slovakia"},{"name":"Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7568-6793","authenticated-orcid":false,"given":"Martin","family":"Suchansk\u00fd","sequence":"additional","affiliation":[{"name":"PharmIn Ltd., Karad\u017ei\u010dova 16, 82108 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So\u0148a V\u00e1ndor","family":"Svidov\u00e1","sequence":"additional","affiliation":[{"name":"PharmIn Ltd., Karad\u017ei\u010dova 16, 82108 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katar\u00edna","family":"Hrubi\u0161kov\u00e1","sequence":"additional","affiliation":[{"name":"Centre for Hereditary Angioedema, Allergy-Immunology Outpatient Clinic, 5th Internal Clinic, Faculty of Medicine, Comenius University and Slovak Medical University, 83303 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Zeln\u00edkov\u00e1","sequence":"additional","affiliation":[{"name":"Immunoallergology JZ, Ltd., Faculty Hospital, 01207 \u017dilina, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8851-2809","authenticated-orcid":false,"given":"Karol\u00edna","family":"Vor\u010d\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Jessenius Faculty of Medicine in Martin, Comenius University in Slovakia, University Teaching Hospital, 03659 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-2523","authenticated-orcid":false,"given":"Milo\u0161","family":"Jese\u0148\u00e1k","sequence":"additional","affiliation":[{"name":"National Centre for Hereditary Angioedema, Department of Paediatrics and Adolescent Medicine, Department of Pulmonology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Slovakia, University Teaching Hospital, 03659 Martin, Slovakia"},{"name":"Institute of Clinical Immunology and Medical Genetics, Jessenius Faculty of Medicine in Martin, Comenius University in Slovakia, University Teaching Hospital, 03659 Martin, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(63)90162-1","article-title":"A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C\u20321-esterase","volume":"35","author":"Donaldson","year":"1963","journal-title":"Am. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/07853890.2016.1162909","article-title":"Hereditary and acquired C1-inhibitor-dependent angioedema: From pathophysiology to treatment","volume":"48","author":"Zeerleder","year":"2016","journal-title":"Ann. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1398-9995.2010.02433.x","article-title":"Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: A 21-month prospective study in a cohort of 103 patients","volume":"66","author":"Zanichelli","year":"2011","journal-title":"Allergy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2009.09366.x","article-title":"Hereditary angio-oedema in Denmark: A nationwide survey","volume":"161","author":"Bygum","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100885","DOI":"10.1016\/j.waojou.2024.100885","article-title":"Complex analysis of the national Hereditary angioedema cohort in Slovakia\u2014Identification of 12 novel variants in SERPING1 gene","volume":"17","author":"Markocsy","year":"2024","journal-title":"World Allergy Organ. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angio-oedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"key":"ref_7","unstructured":"Jese\u0148\u00e1k, M., Hrubi\u0161kov\u00e1, K., Suchansk\u00fd, M., and Ondru\u0161ov\u00e1, M. (2023, January 4\u20137). Quality of life, disease control and mental health in patients with he-reditary angioedema in Slovakia\u2014National online survey. Proceedings of the 13th C1-Inhibitor Deficiency and Angioedema Workshop, Budapest, Hungary."},{"key":"ref_8","first-page":"1","article-title":"Altered C1 inhibitor genes in type I hereditary angioedema","volume":"317","author":"Tosi","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18176\/jiaci.0653","article-title":"Treatment of Hereditary Angioedema","volume":"31","author":"Caballero","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-021-01717-4","article-title":"Clinical characteristics and burden of illness in patients with hereditary angioedema: Findings from a multinational patient survey","volume":"16","author":"Mendivil","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1537-2995.2005.00602.x","article-title":"Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema","volume":"45","author":"Bork","year":"2005","journal-title":"Transfusion"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2500\/aap.2019.40.4267","article-title":"Hereditary and acquired angioedema","volume":"40","author":"Patel","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0091217419837068","article-title":"The impact of hereditary angioedema on quality of life and family planning decisions","volume":"54","author":"Gokmen","year":"2019","journal-title":"Int. J. Psychiatry Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1750-1172-9-99","article-title":"Socioeconomic burden of hereditary angioedema: Results from the hereditary angioedema burden of illness study in Europe","volume":"9","author":"Bygum","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_15","unstructured":"(2001). Labour Code, Ministry of Labour, Social Affairs and Family of the Slovak Republic."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/all.12007","article-title":"Development and construct validation of the angioedema quality of life questionnaire","volume":"67","author":"Weller","year":"2012","journal-title":"Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1477-7525-10-82","article-title":"Development of a Disease-Specific Qual-ity of Life Questionnaire for Adult Patients with Hereditary Angioedema Due to C1 Inhibitor Deficiency (HAE-QoL): Spanish Multi-Centre Research Project","volume":"10","author":"Prior","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/all.14144","article-title":"Development of the Angioedema Control Test\u2014A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema","volume":"75","author":"Weller","year":"2020","journal-title":"Allergy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jaip.2020.02.038","article-title":"Validation of the Angioedema Control Test (AECT)\u2014A Patient-Reported Outcome Instrument for Assessing Angioedema Control","volume":"8","author":"Weller","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_20","unstructured":"(2022, June 10). Angioedema Control Test 4 Weeks Recall Period (AECT4). Available online: https:\/\/moxie-gmbh.de\/products\/angioedema-control-test-4-week-aect4."},{"key":"ref_21","unstructured":"Zigmond, A.S., and Snaith, R.P. (1994). The Hospital Anxiety and Depression Scale, GL Assessment. Manual."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.150.3.387","article-title":"The concepts of mild depression","volume":"150","author":"Snaith","year":"1987","journal-title":"Br. J. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archpsyc.1974.01760160005001","article-title":"Endogenomorphic depression","volume":"31","author":"Klein","year":"1974","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_25","unstructured":"(2022, June 15). Microsoft Forms. Available online: https:\/\/forms.office.com\/."},{"key":"ref_26","unstructured":"(2020). Data Science Workbench, Version 14. TIBCO Software Inc.. Available online: http:\/\/tibco.com."},{"key":"ref_27","unstructured":"Ondru\u0161ov\u00e1, M., Maronov\u00e1, M., Kyselicov\u00e1, A., and Jese\u0148\u00e1k, M. (2024, June 04). Analysis of Target Population Size and Selected Descriptive Characteristics of Patients with Hereditary Angioedema in Slovakia. 2. Rev. Pharm-In 2022; Electronic Publication Nr. 05042022460. Available online: http:\/\/http:\/\/www.pharmin.sk."},{"key":"ref_28","unstructured":"Statistical Office of the Slovak Republic (2022, May 12). Average Monthly Wage of An Employee in the Economy of the Slovak Re-Public in 2022. Available online: https:\/\/slovak.statistics.sk\/wps\/wcm\/connect\/73a324d0-f02e-4240-9444-0b750a84088c\/Priemerna_mesacna_mzda_zamestnanca_hospodarstva_SR_v_roku_2022.pdf?MOD=AJPERES&CVID=oqyfpNo&CVID=oqyfpNo&CVID=oqyfpNo&CVID=oqyfpNo&CVID=oqyfpNo&CVID=oqyfpNo&CVID=oqyfpNo&CVID=oqyfpNo."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12016-021-08850-9","article-title":"How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?","volume":"61","author":"Balla","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2013.05.028","article-title":"Depression and anxiety in patients with hereditary angioedema","volume":"112","author":"Fouche","year":"2014","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13223-022-00664-4","article-title":"Long-term prophylaxis with lanadelumab for HAE: Authorization for temporary use in France","volume":"18","author":"Fain","year":"2022","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1159\/000514973","article-title":"Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany","volume":"182","author":"Zarnowski","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5415\/apallergy.0000000000000172","article-title":"Quality of life in patients with hereditary angioedema correlates with angioedema control: Our experience at Chandigarh, India","volume":"15","author":"Sharma","year":"2025","journal-title":"Asia Pac. Allergy"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lapina, L., Kanepa, A., Zolovs, M., Buttgereit, T., and Kurjane, N. (2025). Adaptation and linguistic validation of angioedema PROMs in Latvian for assessing recurrent aangioedema. J. Clin. Med., 14.","DOI":"10.20944\/preprints202501.2248.v1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1346-8138.17421","article-title":"Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes","volume":"52","author":"Hide","year":"2025","journal-title":"J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-021-00563-0","article-title":"Psychosocial burden of type 1 and 2 hereditary angioedema: A single-center Canadian cohort study","volume":"17","author":"Goodyear","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2021.42.200127","article-title":"Assessing the cost and quality-of-life impact of on-demand\u2013only medications for adults with hereditary angioedema","volume":"42","author":"Castaldo","year":"2021","journal-title":"Allergy Asthma Proc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12900","article-title":"The Angioedema Quality of Life Questionnaire (AE-QoL)\u2014Assessment of sensitivity to change and minimal clinically important difference","volume":"71","author":"Weller","year":"2016","journal-title":"Allergy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13023-024-03247-1","article-title":"An international survey assessing the effects of the duration of attack-free period on health-related quality of life for patients with hereditary angioedema","volume":"19","author":"Itzler","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14680","article-title":"Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study","volume":"76","author":"Lumry","year":"2021","journal-title":"Allergy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13023-024-03265-z","article-title":"Epidemiology, economic, and humanistic burden of hereditary angioedema: A systematic review","volume":"19","author":"Guan","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e12295","DOI":"10.1002\/clt2.12295","article-title":"Sensitivity to change and minimal clinically important difference of the angioedema control test","volume":"13","author":"Fijen","year":"2023","journal-title":"Clin. Transl. Allergy"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:26:37Z","timestamp":1775557597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["medicina62040705"],"URL":"https:\/\/doi.org\/10.3390\/medicina62040705","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}